These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2679841

  • 1. Acute and cumulative effects of carboplatin on renal function.
    Sleijfer DT, Smit EF, Meijer S, Mulder NH, Postmus PE.
    Br J Cancer; 1989 Jul; 60(1):116-20. PubMed ID: 2679841
    [Abstract] [Full Text] [Related]

  • 2. Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients.
    Fokkema E, de Vries EG, Meijer S, Groen HJ.
    Cancer Chemother Pharmacol; 2000 Jul; 45(1):89-92. PubMed ID: 10647508
    [Abstract] [Full Text] [Related]

  • 3. Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin.
    Metz-Kurschel U, Kurschel E, Niederle N, Aulbert E.
    J Cancer Res Clin Oncol; 1990 Jul; 116(2):203-6. PubMed ID: 2182639
    [Abstract] [Full Text] [Related]

  • 4. Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6).
    Offerman JJ, Meijer S, Mulder NH, Sleijfer DT, Bijster P, Hellendoorn HB, Donker AJ, van der Hem GK.
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):447-51. PubMed ID: 3891361
    [Abstract] [Full Text] [Related]

  • 5. Renal dysfunction following high-dose carboplatin treatment.
    Mulder PO, Sleijfer DT, de Vries EG, Uges DR, Mulder NH.
    J Cancer Res Clin Oncol; 1988 Apr; 114(2):212-4. PubMed ID: 3280573
    [Abstract] [Full Text] [Related]

  • 6. Carboplatin and renal function.
    Smit EF, Sleijfer DT, Meijer S, Mulder NH, Postmus PE.
    Ann Intern Med; 1989 Jun 15; 110(12):1034. PubMed ID: 2658713
    [No Abstract] [Full Text] [Related]

  • 7. Effect of oxoplatinum and CBDCA on renal functions in rats.
    Láznícková A, Semecký V, Láznícek M, Zubr V, Koksál J, Kvĕtina J.
    Neoplasma; 1989 Jun 15; 36(2):161-9. PubMed ID: 2654665
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of gemcitabine on renal function in patients with non-small cell lung cancer.
    Gietema JA, Groen HJ, Meijer S, Smit EF.
    Eur J Cancer; 1998 Jan 15; 34(1):199-202. PubMed ID: 9624259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dose-related nephrotoxicity of carboplatin in children.
    English MW, Skinner R, Pearson AD, Price L, Wyllie R, Craft AW.
    Br J Cancer; 1999 Sep 15; 81(2):336-41. PubMed ID: 10496362
    [Abstract] [Full Text] [Related]

  • 16. Effect of oral cyclosporin on renal function in Crohn's disease.
    Lobo AJ, Juby LD, Smith AH, Foster PN, Rothwell J, Pentith J, Poole TW, Axon AT.
    Dig Dis Sci; 1993 Sep 15; 38(9):1624-30. PubMed ID: 8359074
    [Abstract] [Full Text] [Related]

  • 17. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR, Leibowitz AB, Miller CM, Silverstein JH, Schwartz M, Delgiudice R, Vallabhajosula S, Oropello JM, Benjamin E.
    J Am Coll Surg; 1996 Apr 15; 182(4):347-52. PubMed ID: 8605558
    [Abstract] [Full Text] [Related]

  • 18. Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).
    Skillen AW, Buamah PK, Cantwell BM, Cornell C, Hodson AW, Harris AL.
    Cancer Chemother Pharmacol; 1988 Apr 15; 22(3):228-34. PubMed ID: 3044631
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT, Fels LM, Franzke A, Knop S, Renn M, Maess B, Panagiotou P, Lampe H, Kanz L, Stolte H, Bokemeyer C.
    Anticancer Res; 2000 Apr 15; 20(5C):3767-73. PubMed ID: 11268452
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC.
    Am J Physiol Renal Physiol; 2003 May 15; 284(5):F1115-9. PubMed ID: 12676739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.